Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aron Goldhirsch

Showing results (61-70 of 283) with videos related to

Pageof 29
Sort By:
Breast (Edinburgh, Scotland)|October 1, 2013
Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibriumGiuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Best management of locally advanced inoperable breast cancerGiuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.
Expert Opinion on Investigational Drugs|January 11, 2012
Targeting the subtypes of breast cancer: rethinking investigational drugsGiuseppe Curigliano, Marzia Locatelli, Luca Fumagalli, et al.
Anticancer Research|June 30, 2016
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of RecurrenceCarmen Criscitiello, Vincenzo Bagnardi, Giuseppe Viale, et al.
The Annals of Pharmacotherapy|October 26, 2006
Erlotinib-induced breast cancer regressionChiara Catania, Tommaso Martino De Pas, Giuseppe Pelosi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2013
No link between breast cancer and meningioma: results from a large monoinstitutional retrospective analysisCarmen Criscitiello, Davide Disalvatore, Michele Santangelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2003
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancerAron Goldhirsch, William C Wood, Richard D Gelber, et al.
Anti-Cancer Drugs|July 5, 2012
Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?Angela Esposito, Elisabetta Munzone, Vincenzo Bagnardi, et al.
Cancer Treatment Reviews|March 23, 2010
Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomyAlessandra Balduzzi, Maria Cristina Leonardi, Anna Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the MicrobiomeLaura Pala, Luigi Nezi, Tommaso De Pas, et al.
Pageof 29

Showing results (61-70 of 283) with videos related to

Sort By:
Pageof 29
Breast (Edinburgh, Scotland)|October 1, 2013
Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibriumGiuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Best management of locally advanced inoperable breast cancerGiuseppe Curigliano, Carmen Criscitiello, Angela Esposito, et al.
Expert Opinion on Investigational Drugs|January 11, 2012
Targeting the subtypes of breast cancer: rethinking investigational drugsGiuseppe Curigliano, Marzia Locatelli, Luca Fumagalli, et al.
Anticancer Research|June 30, 2016
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of RecurrenceCarmen Criscitiello, Vincenzo Bagnardi, Giuseppe Viale, et al.
The Annals of Pharmacotherapy|October 26, 2006
Erlotinib-induced breast cancer regressionChiara Catania, Tommaso Martino De Pas, Giuseppe Pelosi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2013
No link between breast cancer and meningioma: results from a large monoinstitutional retrospective analysisCarmen Criscitiello, Davide Disalvatore, Michele Santangelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2003
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancerAron Goldhirsch, William C Wood, Richard D Gelber, et al.
Anti-Cancer Drugs|July 5, 2012
Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?Angela Esposito, Elisabetta Munzone, Vincenzo Bagnardi, et al.
Cancer Treatment Reviews|March 23, 2010
Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomyAlessandra Balduzzi, Maria Cristina Leonardi, Anna Cardillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2018
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the MicrobiomeLaura Pala, Luigi Nezi, Tommaso De Pas, et al.
Pageof 29